Altamira Therapeutics Ltd. (CYTO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Altamira Therapeutics Ltd...

    NASDAQ: CYTO · Real-Time Price · USD
    0.30
    0.00 (0.00%)
    At close: Jan 16, 2025, 10:00 PM

    Altamira Therapeutics Ratios and Metrics

    Financials in CHF. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.2 -0.15 -1.26
    PEG Ratio
    		 0.00 -0.01 0.34
    PS Ratio
    		 n/a 13.36 343.11
    PB Ratio
    		 0.22 -0.49 1.73
    P/FCF Ratio
    		 -0.12 -0.38 -1.29
    P/OCF Ratio
    		 -0.12 -0.47 -1.6
    OCF/S Ratio
    		 n/a -28.41 -214.03
    Debt / Equity Ratio
    		 0.02 -0.76 0.05
    Quick Ratio
    		 1.38 0.14 0.60
    Current Ratio
    		 1.38 0.14 0.77
    Asset Turnover
    		 n/a 0.05 0.00
    Interest Coverage
    		 n/a -28.66 -90.14
    Return on Equity
    		 -1.13 3.19 -1.37
    Return on Assets
    		 -0.94 -4.21 -0.92
    Return on Invested Capital
    		 -0.86 44.33 -1.21
    Dividend Yield
    		 n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a
    Gross Profit Margin
    		 n/a -3.72 -34.07
    Net Profit Margin
    		 n/a -86.8 -272.22
    Pretax Profit Margin
    		 n/a -86.84 -271.88
    Operating Profit Margin
    		 n/a -85.51 -267.68
    FCF Margin
    		 n/a n/a n/a
    EBITDA Margin
    		 n/a -57.71 -105.13

    Add to Watchlist